Improving maternal health through mobile messaging
Testing the Effectiveness of Quality-Based WhatsApp Messaging on Vaccine Hesitancy and Childhood Immunization in a National Maternal Messaging Program
NA · IDinsight · NCT05505760
This study tests whether sending health messages through WhatsApp can help pregnant women improve their health practices and outcomes, especially in areas that need more support.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 8867 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | IDinsight (other) |
| Locations | 1 site (Cape Town) |
| Trial ID | NCT05505760 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of mobile health (mHealth) content delivery models, specifically through the MomConnect platform, which provides health messaging to pregnant women. By utilizing WhatsApp, the program aims to enhance immunization coverage, breastfeeding practices, and address hematological diseases among mothers. The intervention focuses on quality-based digital messaging to support health outcomes in under-resourced areas. With a history of supporting over 1.28 million mothers, this initiative seeks to optimize communication and health education during pregnancy and early childhood.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women over the age of 18 who are between 16-30 weeks pregnant and signing up for MomConnect.
Not a fit: Patients who are not pregnant or those outside the specified age and gestational criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this could significantly improve maternal and child health outcomes by enhancing access to vital health information.
How similar studies have performed: Other mHealth initiatives have shown success in improving health outcomes, indicating that this approach has potential based on previous evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women above the age of 18 signing up for MomConnect when being between 16-30 weeks pregnant Exclusion Criteria: * All others
Where this trial is running
Cape Town
- Reach Digital Health (formerly Praekelt.org) — Cape Town, South Africa (RECRUITING)
Study contacts
- Study coordinator: Philipp M Kastrau, PhD
- Email: philipp.kastrau@idinsight.org
- Phone: +254746649552
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Immunization Coverage, Breastfeeding, Hematological Diseases